Literature DB >> 22956169

Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.

Mette Hamborg1, Lene Jorgensen, Anders Riber Bojsen, Dennis Christensen, Camilla Foged.   

Abstract

PURPOSE: Understanding the nature of adjuvant-antigen interactions is important for the future design of efficient and safe subunit vaccines, but remains an analytical challenge. We studied the interactions between three model protein antigens and the clinically tested cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) and trehalose 6,6'-dibehenate (TDB).
METHODS: The effect of surface adsorption to DDA/TDB liposomes on colloidal stability and protein physical stability/secondary structure was investigated by dynamic light scattering, circular dichroism, Fourier transform infrared spectroscopy and differential scanning calorimetry.
RESULTS: Bovine serum albumin and ovalbumin showed strong liposome adsorption, whereas lysozyme did not adsorb. Upon adsorption, bovine serum albumin and ovalbumin reduced the phase transition temperature and narrowed the gel-to-liquid phase transition of the liposomes implying interactions with the lipid bilayer. The protein-to-lipid ratio influenced the liposome colloidal stability to a great extent, resulting in liposome aggregation at intermediate ratios. However, no structural alterations of the model proteins were detected.
CONCLUSIONS: The antigen-to-lipid ratio is highly decisive for the aggregation behavior of DDA/TDB liposomes and should be taken into account, since it may have an impact on general vaccine stability and influence the choice of analytical approach for studying this system, also/especially at clinically relevant protein-to-lipid ratios.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956169     DOI: 10.1007/s11095-012-0856-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

1.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

2.  Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Authors:  Jesper Davidsen; Ida Rosenkrands; Dennis Christensen; Anil Vangala; Daniel Kirby; Yvonne Perrie; Else Marie Agger; Peter Andersen
Journal:  Biochim Biophys Acta       Date:  2005-11-14

Review 3.  Egg white proteins.

Authors:  L Stevens
Journal:  Comp Biochem Physiol B       Date:  1991

4.  Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines.

Authors:  Salvador F Ausar; Judy Chan; Warda Hoque; Olive James; Kavisha Jayasundara; Kevin Harper
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

5.  Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states.

Authors:  B S Kendrick; A Dong; S D Allison; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

Review 6.  Serum albumin.

Authors:  T Peters
Journal:  Adv Protein Chem       Date:  1985

7.  Circular dichroism analyses of membrane proteins: an examination of differential light scattering and absorption flattening effects in large membrane vesicles and membrane sheets.

Authors:  B A Wallace; D Mao
Journal:  Anal Biochem       Date:  1984-11-01       Impact factor: 3.365

8.  Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.

Authors:  LaToya S Jones; Laura J Peek; Jonathan Power; Aaron Markham; Brian Yazzie; C Russell Middaugh
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

9.  Enhanced liposomal vaccine formulation and performance: simple physicochemical and immunological approaches.

Authors:  Vanessa de Almeida Silva; Célia Sayoko Takata; Osvaldo A Sant'Anna; Antônio Carlos Lopes; Pedro Soares de Araujo; Maria Helena Bueno da Costa
Journal:  J Liposome Res       Date:  2006       Impact factor: 3.648

Review 10.  Vaccines for the twenty-first century society.

Authors:  Rino Rappuoli; Christian W Mandl; Steven Black; Ennio De Gregorio
Journal:  Nat Rev Immunol       Date:  2011-11-04       Impact factor: 53.106

View more
  10 in total

1.  Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction.

Authors:  Meiping Yan; Xinhua Zhang; Ao Chen; Wei Gu; Jie Liu; Xiaojiao Ren; Jianping Zhang; Xiaoxiong Wu; Aaron T Place; Richard D Minshall; Guoquan Liu
Journal:  FASEB J       Date:  2017-07-12       Impact factor: 5.191

2.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

3.  Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.

Authors:  Pall Thor Ingvarsson; Mingshi Yang; Helle Mulvad; Hanne Mørck Nielsen; Jukka Rantanen; Camilla Foged
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

4.  Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.

Authors:  Aneesh Thakur; Cristina Rodríguez-Rodríguez; Katayoun Saatchi; Fabrice Rose; Tullio Esposito; Zeynab Nosrati; Peter Andersen; Dennis Christensen; Urs O Häfeli; Camilla Foged
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

5.  Synthesis of protein conjugates adsorbed on cationic liposomes surface.

Authors:  Despo Chatzikleanthous; Robert Cunliffe; Filippo Carboni; Maria Rosaria Romano; Derek T O'Hagan; Craig W Roberts; Yvonne Perrie; Roberto Adamo
Journal:  MethodsX       Date:  2020-05-28

6.  Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis.

Authors:  Marcelo Valdemir de Araújo; Samuel Rodrigues Dos Santos Júnior; Joshua D Nosanchuk; Carlos Pelleschi Taborda
Journal:  J Fungi (Basel)       Date:  2020-12-08

Review 7.  Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform.

Authors:  Nawamin Sa-Nguanmoo; Katawut Namdee; Mattaka Khongkow; Uracha Ruktanonchai; YongXiang Zhao; Xing-Jie Liang
Journal:  Nano Res       Date:  2021-10-09       Impact factor: 10.269

Review 8.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

9.  The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.

Authors:  Signe Tandrup Schmidt; Swapnil Khadke; Karen Smith Korsholm; Yvonne Perrie; Thomas Rades; Peter Andersen; Camilla Foged; Dennis Christensen
Journal:  J Control Release       Date:  2016-08-26       Impact factor: 9.776

10.  Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction.

Authors:  Katharina Wørzner; Jóhanna Hvannastein; Signe Tandrup Schmidt; Camilla Foged; Ida Rosenkrands; Gabriel Kristian Pedersen; Dennis Christensen
Journal:  Eur J Pharm Biopharm       Date:  2021-05-24       Impact factor: 5.571

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.